Cigna's (CI) 2022 Expansion Plans to Boost MA Customer Base
Cigna (CI) unveils enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties and states to offer enhanced...
Cigna Corporation CI recently introduced its Medicare Advantage plans for 2022, which marks the third straight year of record geographic extension in Medicare Advantage (“MA”). The healthcare provider boasts of a strong MA network across the United States. Through this vast network, it has been consistently delivering cost-effective plans and catering to the diversified health needs of individuals.
With the expansion endeavor of 2022, Cigna intends to bolster its geographic reach with inclusion of 108 new counties, which comprises territories across three new states — Connecticut, Oregon, and Washington. Consequently, the latest announcement paves the way for the company’s MA business to serve 477 counties spread across 26 states and the District of Columbia.
During the 2022 Medicare Annual Election Period (“AEP”), which will start Oct 15 and run through Dec 7 this year, the plans available for purchase will be extensive and cost-effective ones and include several enhanced benefits. Besides, Cigna will distribute three stand-alone Prescription Drug Plans (“PDPs”) throughout the United States during next year. For specific Dual Special Needs Plans (“DSNP”), through which the company aims to serve people eligible for both Medicare and Medicaid, Cigna will provide a debit card to enable customers to pay for particular expenses.
These measures lead to improved health outcomes for Cigna’s MA customers as they have easy access to high-quality MA plans best suited to their diversified health needs.
Initiatives similar to the latest one underscore Cigna’s sincere efforts to bolster its MA customer base, which in turn, is expected to drive the company’s MA business. Since 2019, the geographic existence of the healthcare provider’s MA business has been boosted by 80%. The business has performed well courtesy of constant product expansions, growing membership, and new collaborations or contract extensions with renowned healthcare systems. This has been bolstering Cigna’s partner networks and strengthening its U.S. footprint.
Concurrently, growth in MA customers has fetched higher premiums for the company. This is quite evident from the top-line growth of 8.2% in the first half of 2021. Cigna remains well on track to achieve MA customer growth in the targeted range of 10-15% this year.
The MA market seems to be an attractive one for the company, considering the surge in enrollment figures and a growing U.S. aging population. It is worth mentioning that MA plans remain the preferred choice for consumers owing to several bundled benefits, improved care coordination and affordable nature, which make them a better option when compared to the traditional Medicare plans. Consequently, employers are intensifying focus on offering health insurance coverage to its retirees through rolling out a significant number of these plans.
For items that Original Medicare does not provide coverage to, Cigna provides Medicare Supplement plans across 48 states and the District of Columbia.
Another healthcare provider, UnitedHealth Group Incorporated UNH, also declared its 2022 MA and prescription drug plans recently. In the next year, the company will expand its service area to reach 94% of Medicare consumers nationwide
Zacks Rank & Price Performance
Shares of Cigna, which carries a Zacks Rank #3 (Hold), have gained 17.7% in a year compared with the industry’s growth of 19.6%.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the medical space include The Joint Corp. JYNT and Acadia Healthcare Company, Inc. ACHC, both carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Joint Corp. and Acadia Healthcare have a trailing four-quarter earnings surprise of 235.00% and 26.14%, on average, respectively.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
Cigna Corporation (CI): Free Stock Analysis Report
Acadia Healthcare Company, Inc. (ACHC): Free Stock Analysis Report
The Joint Corp. (JYNT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research